An Automated Peak Identification/Calibration Procedure for High-Dimensional Protein Measures from Mass Spectrometers

Journal of Biomedicine and Biotechnology

Volumn 2003, Issue 4, 2003, Pages 242-248

  Yasui, Yutaka ^a   McLerran, Dale ^a   Adam, Bao Ling ^b   Winget, Marcy ^a   Thornquist, Mark ^a   Feng, Ziding ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CALIBRATION; HUMAN; MASS SPECTROMETER; MASS SPECTROMETRY; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEOMICS;

EID: 0346101457     PISSN: 11107243     EISSN: None     Source Type: Journal    
DOI: 10.1155/S111072430320927X     Document Type: Article

References (13)

1. Srinivas PR, Srivastava S, Hanash S, Wright GL Jr. Proteomics in early detection of cancer. Clin Chem. 2001;47(10):1901-1911.
2. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002;359(9306):572-577.
3. Ball G, Mian S, Holding F, et al. An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers. Bioinformatics. 2002;18(3):395-404.
4. Adam BL, Qu Y, Davis JW, et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res. 2002;62(13):3609-3614.
5. Qu Y, Adam BL, Yasui Y, et al. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin Chem. 2002;48(10):1835-1843.
6. Yasui Y, Pepe M, Thompson ML, et al. A Data-Analytic Strategy for Protein-Biomarker Discovery: Profiling of High-Dimensional Proteomic Data for Cancer Detection. Biostatistics 2003;4(3):449-463.
7. Srivastava S, Kramer BS. Early detection cancer research network. Lab Invest. 2000;80(8):1147-1148.
8. Verma M, Wright GL Jr, Hanash SM, Gopal-Srivastava R, Srivastava S. Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers. Ann N Y Acad Sci. 2001;945:103-115.
9. Wright GL Jr, Cazares LH, Leung SM, et al. Proteinchip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis. 1999;2(5/6):264-276.
10. Rubin RB, Merchant M. A rapid protein profiling system that speeds study of cancer and other diseases. Am Clin Lab. 2000;19(8):28-29.
11. Adam BL, Vlahou A, Semmes OJ, Wright GL Jr. Proteomic approaches to biomarker discovery in prostate and bladder cancers. Proteomics. 2001;1(10):1264-1270.
12. Paweletz CP, Trock B, Pennanen M, et al. Proteomic patterns of nipple aspirate fluids obtained by SELDITOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis Markers. 2001;17(4):301-307.
13. Rosty C, Christa L, Kuzdzal S, et al. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res. 2002;62(6):1868-1875.